Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
OM-89
Description:
OM-89 is an oral bacterial lysate derived from Escherichia coli and studied for its immunomodulatory effects in medicine.
Primary topic:
Urinary Tract Infections Management (51%)
Related topics:
Urinary Tract Infections Management (51%),
Rheumatoid Arthritis Research and Therapies (8%),
Immune Response and Inflammation (7%)
OpenAlex ID:
keywords/om-89
Nonantibiotic Prophylaxis for Recurrent Urinary Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2013
·
M.A.J. Beerepoot
, S.E. Geerlings
, et al.
·
The Journal of Urology
·
267
Guideline of guidelines: management of recurrent urinary tract infections in women
2022
·
Michael Kwok
, Stephen McGeorge
, et al.
·
British Journal of Urology
·
216
PDF
Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis
2008
·
Kurt G. Naber
, Yong-Hyun Cho
, et al.
·
International Journal of Antimicrobial Agents
·
198
A Long-Term, Multicenter, Double-Blind Study of an Escherichia Coli Extract (OM-89) in Female Patients with Recurrent Urinary Tract Infections
2005
·
Hartwig W. Bauer
, Schanaz Alloussi
, et al.
·
European Urology
·
191
Recurrent Lower Urinary Tract Infections Have a Detrimental Effect on Patient Quality of Life: a Prospective, Observational Study
2014
·
Julien Renard
, Stefania Ballarini
, et al.
·
Infectious Diseases and Therapy
·
184
PDF
Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention
2017
·
Hann-Chorng Kuo
, Jia-Fong Jhang
·
Tzu Chi Medical Journal
·
86
Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats
1998
·
K. Bellmann
, H. Kolb
, et al.
·
Diabetologia
·
64
PDF
A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections
2020
·
Andrew Brodie
, Omar El-Taji
, et al.
·
Current Urology
·
55
Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines
1996
·
H. Kolb
, U. Wörz-Pagenstert
, et al.
·
Diabetologia
·
55
PDF
Vaccine Development for Urinary Tract Infections: Where Do We Stand?
2018
·
Giuseppe Magistro
, Christian G. Stief
·
European Urology Focus
·
51
Oral vaccine (OM-89) in the recurrent urinary tract infection prophylaxis: A realistic systematic review with meta-analysis
2016
·
K.A. Taha Neto
, L. Nogueira Castilho
, et al.
·
Actas Urológicas Españolas (English Edition)
·
44
Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA)
1997
·
A. BLOEMENDAL
, R. VAN DER ZEE
, et al.
·
Clinical & Experimental Immunology
·
44
PDF
Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant
1997
·
B. Hartmann
, K. Bellmann
, et al.
·
Diabetologia
·
41
PDF
A Randomized, Double-Blind, Parallel-Group, Multicenter Clinical Study of Escherichia coli-Lyophilized Lysate for the Prophylaxis of Recurrent Uncomplicated Urinary Tract Infections
2015
·
Florian M.E. Wagenlehner
, Stefania Ballarini
, et al.
·
Urologia Internationalis
·
40
Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies.
1990
·
T Van Pham
, B Kreis
, et al.
·
PubMed
·
40
Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89
2000
·
M Huber
, K Krauter
, et al.
·
International Journal of Immunopharmacology
·
39
Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer
2024
·
Md. Mijanur Rahman
, I. Darren Grice
, et al.
·
Journal of Immunology Research
·
34
Prevention of recurrent urinary tract infections in female children
1996
·
Bernhard Lettgen
·
Current Therapeutic Research
·
33
Enhancement of the Humoral Immune Response and Resistance to Bacterial Infection in Mice by the Oral Administration of a Bacterial Immunomodulator (OM-89)
1988
·
Albert Bosch
, Vicente J. Benedi
, et al.
·
Immunopharmacology and Immunotoxicology
·
33
Enhancement of Cytokine Production and Natural Killer Activity By an Escherichia Coli Extract
2009
·
J. Wybran
, M. Libin
, et al.
·
Onkologie
·
32
Intervention in autoimmune diabetes by targeting the gut immune system
1997
·
Kerstin Bellmann
, Hubert Kolb
, et al.
·
International Journal of Immunopharmacology
·
27
Presence of hsp65 in bacterial extracts (OM-89): A possible mediator of orally-induced tolerance?
1995
·
B. S. Polla
, S. Baladi
, et al.
·
Cellular and Molecular Life Sciences
·
27
An Hypothesis to Link the Opposing Immunological Effects Induced by the Bacterial Lysate OM-89 in Urinary Tract Infection and Rheumatoid Arthritis
2006
·
Carlo Chiavaroli
, Adrian Moore
·
BioDrugs
·
26
Prevention of recurrent urinary tract infections: bridging the gap between clinical practice and guidelines in Latin America
2019
·
José Antonio Ortega Martell
, Kurt G. Naber
, et al.
·
Therapeutic Advances in Urology
·
25
PDF
Biological activity of bacterial cell-wall components: immunogenicity of the bacterial extract OM-89
1995
·
Eva A. Sedelmeier
, Wolfgang G. Bessler
·
Immunopharmacology
·
24
Show more works
View as search
Works count:
102
Citation count:
2,151
Year
Topic
Type